ARCHIVETu lucha, nuestra lucha
La campaña "Tu lucha, nuestra lucha" lanzada en septiembre de 2024 en Colombia, México y Perú para...
How Goldaru Positions CalcitraFix as Iran's Bone Health Answer
CalcitraFix is a specialized bone and dental health supplement marketed by Goldaru in Iran, promoted through a single film asset produced by agency 2milimeters and released in December 2024, with its core proposition built around superior absorption and reduced digestive complications compared with conventional calcium supplements.
Goldaru operates within Iran's healthcare and pharmaceutical consumer goods sector, where growing awareness of osteoporosis and bone density loss is driving demand for scientifically positioned supplements. The CalcitraFix campaign enters this context with a clear clinical identity: the product is framed not merely as a calcium source but as a formulation engineered for better bioavailability, addressing the discomfort that frequently discourages consistent supplement use, according to 6wresearch. That dual emphasis on efficacy and tolerability is the campaign's defining strategic move.
The campaign consists of one film asset, placing the entire creative burden on a single execution, according to Nutripad. In the Iran market, where pharmaceutical advertising frequently relies on functional product demonstration, the choice of film as the sole medium reflects both the agency's production orientation and the brand's confidence in visual storytelling to carry a health claim, according to Pourateb. Agency 2milimeters, which according to Clapboard's archive handled at least eight Goldaru campaigns across 2024, is the credited creative and production partner for this work. The campaign carries a Clapboard Score of 53 out of 100, indicating moderate creative distinction within its category. Published in December 2024, CalcitraFix represents one chapter in a sustained content programme that Goldaru and 2milimeters built together across the bones and broader health industry throughout that year.
Iran's consumer healthcare market presents a specific challenge for bone health brands. Osteoporosis and calcium deficiency are documented public health concerns in the country, and the supplement category is populated by both domestic producers and internationally derived formulations. According to Clapboard's editorial observation, CalcitraFix positions itself by addressing two simultaneous barriers to supplement adherence: perceived inefficacy of standard calcium products and the gastrointestinal side effects that cause users to discontinue use.
The global context for this category is significant. The global bone and joint health supplements market was estimated at approximately fourteen billion US dollars in 2024, with a compound annual growth rate projected at around seven percent through 2033, according to Grand View Research. Allied Market Research places the global bone health supplements market at thirteen point eight billion US dollars with more than five percent compound annual growth projected through 2034. While no Iran-specific market sizing is publicly available from these sources, these global trajectories signal that the structural demand conditions Goldaru is addressing in Iran reflect a worldwide pattern of ageing populations and rising preventive health awareness.
Within Iran's healthcare advertising environment, Goldaru's competitors in the bone supplement and broader nutraceutical space include established pharmaceutical distributors and regional consumer health brands that compete on price and pharmacist recommendation rather than on branded film campaigns. The CalcitraFix strategy distinguishes itself by investing in visual brand identity through 2milimeters, making creative production a point of differentiation in a category that typically relies on in-store or clinical channels. According to information available through goldaruco.com, Goldaru presents itself as a science-forward health brand, which the CalcitraFix campaign reinforces by anchoring its claims in absorption chemistry and digestive safety rather than in lifestyle aspiration alone.
The CalcitraFix campaign communicates its proposition through a single film asset. Production credits for the CalcitraFix campaign are not publicly documented beyond the agency attribution to 2milimeters, meaning no named director, creative director, or cinematographer has been confirmed in available sources. What is documented through Clapboard's archive is the creative context: 2milimeters produced sixteen product videos and four brand films for Goldaru during 2023 and 2024, according to information catalogued by Clapboard, indicating a mature and iterative production relationship between the agency and the brand.
That volume of output suggests CalcitraFix was not conceived in isolation. It emerged from a systematic content programme in which each Goldaru product received its own film treatment calibrated to its specific health claim and target audience. For a bone and dental health supplement, the creative task is to make an internal biological process — calcium absorption at the cellular level — legible and motivating to a general consumer in Iran. Healthcare film campaigns that succeed in this territory typically use a combination of body-focused animation or demonstration, authoritative voiceover, and clean visual aesthetics that signal pharmaceutical credibility without triggering regulatory concerns.
The single-asset format also implies focused media deployment. Rather than a campaign architecture built across multiple touchpoints, CalcitraFix concentrates its message into one film intended to function across digital platforms in the Iran market. This is consistent with the production model that 2milimeters appears to operate for Goldaru: purpose-built, product-specific films designed for direct digital distribution. According to Clapboard's archive data, the broader 2024 Goldaru campaign slate by 2milimeters included work for products named Tussian, D-Fix, Ginsin, Sankol, BeautyFix, Memoral, C-Fix, and Afrodit, reflecting a health industry portfolio strategy in which CalcitraFix occupies the bone health segment.
No verified performance data for the CalcitraFix campaign in the form of sales lift, revenue growth, brand awareness shifts, or media reach figures is publicly available. According to Clapboard's archive, the campaign recorded sixty-three views, one like, and zero comments at the time of submission, which represents minimal public engagement at the archive level but does not speak to performance on Goldaru's own distribution channels in Iran.
No trade press coverage of the CalcitraFix campaign has been located from outlets including Campaign, Ad Age, Adweek, The Drum, or Contagious. No verified entries or recognitions appear in the records of Cannes Lions, Effie Awards, The One Show, D&AD, Clio Awards, Webby Awards, or WARC Awards, according to Clapboard's research.
The campaign's Clapboard Score of 53 out of 100 places it at the midpoint of the creative effectiveness scale. Structurally, this score reflects the campaign's focused single-asset execution and clear product proposition, offset by limited evidence of creative ambition beyond functional product communication. For a healthcare supplement film in the Iran market, functional clarity is not a weakness in itself — the ability to articulate a differentiated absorption benefit and a reduced side-effect profile in one film is a genuine creative and strategic achievement. What the score suggests is that the execution, while competent and strategically coherent, does not break new ground in visual language or emotional engagement within the bones and broader health industry category. The campaign's value to Goldaru is most likely operational: sustaining a consistent brand voice across a large product portfolio through a reliable production partner in 2milimeters, rather than generating a single landmark piece of communication.
CalcitraFix is a film campaign created by 2milimeters for Goldaru and published in Iran in December 2024. It promotes a bone and dental health supplement formulated for better absorption and reduced digestive side effects. The campaign consists of one film asset and targets consumers seeking an effective osteoporosis prevention and bone density supplement.
Agency 2milimeters created the CalcitraFix campaign for Goldaru. According to Clapboard's archive, 2milimeters served as Goldaru's primary creative and production partner across at least eight campaigns in 2024, producing product and brand films across the brand's health industry portfolio in Iran, including CalcitraFix as its bone health entry.
CalcitraFix is positioned as a specialized supplement for bone and dental health and osteoporosis prevention. Its defining claims centre on superior absorption compared with conventional calcium products and minimal digestive complications, making it suitable for consumers who have previously found standard bone health supplements difficult to tolerate consistently over time.
The CalcitraFix campaign by Goldaru holds a Clapboard Score of 53 out of 100. This midpoint score reflects a structurally clear and strategically coherent single-film execution with a differentiated product proposition, offset by limited evidence of visual or emotional ambition that would distinguish it further within Iran's competitive healthcare advertising landscape.
CalcitraFix occupies the bone health segment of Goldaru's 2024 product campaign portfolio. According to Clapboard's archive, 2milimeters produced campaigns for at least eight Goldaru products that year, including Tussian, D-Fix, Sankol, BeautyFix, and Memoral, forming a systematic health industry content programme in Iran built around individual product film executions.
No verified awards recognition for CalcitraFix has been found in records from Cannes Lions, Effie Awards, Clio Awards, D&AD, The One Show, or WARC Awards, according to Clapboard's research. No published sales lift or audience reach data is publicly available, and no trade press coverage of the campaign has been located from major industry publications.
.webp)
Creative Collaboration Platform: The Backbone of Modern Creative WorkWhat is a creative collaboration platform?Clapboard defines a creative collaboration platform as the operational core for today’s distributed creative teams. This is not a collection of digital collaboration tools stitched together; Clapboard’s system
Understanding the Creative Production MarketplaceWhat is a Creative Production Marketplace?Clapboard defines a creative production marketplace as a structured ecosystem where brands, agencies, and production talent converge to execute video, advertising, and branded content at scale. Unlike the legacy agency or freelanREAD FULL ARTICLE
The Urgent Need for a Creative Production Operating SystemWhy Traditional Creative Production Models Break DownClapboard sees the creative production landscape shifting under pressure. Content velocity is no longer a buzzword—it’s a mandate. Modern advertising demands relentless output across dozens of channels, each wREAD FULL ARTICLE
